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Mothylmercury-Cholinesterase
Interactions in Rats
by Felton L. Hastings,* George W. Lucier,t and Ronald
Kleini
The interaction ofmethylmercury hydroxide (MMH) and cholinesterases was studied in
male and female rats. MMH administered subcutaneously in doses of 10 mg/kg for 2 days
reduced the level of plasma cholinesterase (ButChE) by 68% in females and 47% in males
while brain acetylcholinesterase (AChE) was unaffected. Normal females had higher but
more variable ButChE levels than normal males. In a time-course experiment, a single
dose of MMH (10 mg/kg) reduced ButChE levels when mercury levels reached 22 ,ug/ml in
the blood. A 10% reduction in brain AChE was observed at 72 hours; however, mercury
reached a concentration ofonly 2.0 ,tg/g in brain tissue. The determination ofthe Michaelis
constant Km and maximum velocity value Vmax for butyrylcholine and ButChE in control
and MMH-treated (1 mg/kg) animals indicated that MMH reduced Vmax only. Since no loss
in ButChE activity occurred when MMH and control plasma were incubated in vitro, MMH
is not a direct inhibitor of ButChE. Because only the inactive monomeric form of ButChE
contains free sulfhydryl groups, it is postulated that MMH combines covalently with the
sulfur, preventing formation of active enzyme. By analogy, it is believed this is also the
case with AChE.
Organophosphorus and carbamate insectides
are known to inhibit butyrylcholinesterase
(ButChE) and acetylcholinesterase (AChE) in
warm-blooded animals and inhibition of these
enzymes is considered to be the mode of action of
these pesticides. Recent findings have demon-
strated a lowering of the LD5o value of carbaryl to
rats pretreated with methylmercury hydroxide
(MMH) (1) that might be related to decreased
hepatic mixed function oxidase activity (2). It is
also possible that MMH has an effect on ButChE
and AChE that might be related to decreased LD5o
values. To investigate this possibility, we pretre-
ated rats with MMH and compared the ButChE
levels in the plasma and AChE levels in the brain
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to control levels. Preliminary investigations indi-
cated that sex differences could be an important
consideration in this study. Dose-response rela-
tionships and time-course effects were also in-
vestigated to understand further the interactions
between these enzymes and MMH.
Materials and Methods
Adult albino Charles River C-D male and
female rats weighing 175-225 g were maintained
in individual suspended cages, fed ad libitum, and
weighed daily. Treated rats received subcutaneous
(SC) injections of MMH (97% pure by NMR
spectroscopy) in an aqueous solution, while control
animals received injections ofdistilled water on the
same schedule as the treated animals. The precau-
tions for handling and administering the highly
toxic MMH have been described (3). Mercury levels
were determined by neutron activation analysis (4).
December 1975 127Vaginal smears were taken 2 or 4 days prior to
sacrifice to establish the phase of the cycle on the
day of ButChE determination. The maturation in-
dex was established by vaginal cytology measured
by the relative cell count, including parabasal,
small, intermediate, and superficial epithelial cells
as well as leukocytes (5).
Methoxyflurane was used for inhalational
anesthesia, and 4-7 ml of blood was removed by
cardiac puncture and placed in 0.2 ml of heparin.
Plasma was separated from erythrocytes by
centrifuging at 3020 g for 10 min at 4°C. The
plasma was held at 4°C until studied. All analyses
were conducted within 6 hr of sacrifice.
Brain homogenates were prepared by decapita-
tion and rapid removal ofthe entire brain with the
exception ofthe medulla oblongata. The tissue was
weighed, placed in distilled water, and
homogenized to make a 10% mixture (w/v). To pro-
mote solubilization, two drops (or approximately
0.6% ) of Triton X-100 were added prior to
homogenation.
Cholinesterase levels were determined by using
Brinkmann pH stats. Plasma studies were done
with 40 ml of 4mM butyrylcholine iodide and 0.4
ml ofplasma while brain studies were done with 40
ml of 2mM acetylcholine chloride and 0.2 ml of a
10% brain homogenate. Conditions were 25°C and
pH 7.6, and no salts were added. The titrant was
5mM NaOH. Activities are expressed as
Amole/min-ml for plasma and ,umole/min-g for
brain and all measurements were corrected for
nonenzymatic hydrolysis. Enzyme kinetic cons-
tants were determined according to the method of
Lineweaver and Burk (6). Linear regression
analyses were performed according to Steel and
Torrie (7).
Results and Discussion
At 48 hr following two SC doses of MMH at 10
mg/kg the level of AChE as measured by
acetylcholine hydrolysis wasessentially unchanged
for males (mean ± SE for controls 5.40 ± 0.09
,umole/min-g and for MMH-treated 5.36 ± 0.09
,mole/min-g. For females the level of AChE only
decreased 4% (mean ± SE for controls 5.60 ± 0.20
/.Lmole/min-g and for MMH-treated 5.36 ± 0.20
,tmole/min-g). This may represent the lag period
characteristic of short-chain alkyl mercurials
which are bound to red blood cells prior to diffus-
ing into the brain (8). Norseth and Clarkson (9)
have demonstrated in rats that red blood cells
preferentially accumulated methylmercury
chloride which resulted in a cell to plasma ratio of
300:1. The time-course experiment which follows
substantiates the slow movement ofMMH into the
brain.
In a similar experiment at the same MMH
dosage rate, MMH reduced the ButChE levels by
68% in females as measured by butyrylcholine hy-
drolysis (mean ± SE for controls 0.743 ± 0.138
,umole/min-ml and for MMH-treated 0.237 +
0.011 ,tmole/min-ml). For males the level of
ButChE wasreduced 47% (mean ± SE for controls
0.150 ± 0.014 ,umole/min-ml and for MMH-treated
0.070 ± 0.009 ,umole/min-ml). The amount of
MMH administered (10 mg/kg on each of 2 days
prior to sacrifice) was quite high since the dose-
response curve showed near maximum reduction in
the level of the enzyme at about 5 mg/kg (Fig. 1).
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FIGURE 1. Effect ofvarying doses ofmethylmercury hydroxide
(MMH) on the level on plasma cholinesterase in female rats.
Each point is the mean value for the number of animals in-
dicated near each point. The bars indicate the standard
deviations of the mean values. Animals received 1 SC
dose/day for 2 days prior to sacrifice.
However, this was the MMH dosage schedule used
to decrease the LD5o value for carbaryl (1); on this
schedule rats did not exhibit neurological
symptoms, liver histopathology, or weight loss (10).
There was a large variation between the individual
control females. Male rats were not as variable nor
as high in ButChE activity as were females.
It appeared that the high variability might be
sex-associated and therefore related to the 4-day
estrus cycle. We did observe a correlation between
ButChE activity and the phase ofthe cycle, i.e., the
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128closer to estrus, the higher the titer of ButChE. In
addition, MMH decreased ButChE activity in all
phases of the estrus cycle.
Figure 2 shows the time-course study for females
receiving one dose of 10 mg/kg of MMH. ButChE
levels decreased to 71% of normal at 24 hr when
mercury levels reached 21.7 ,ug/g. Depression of
ButChE levels continued during the 336-hr test
period, although niercury levels gradually
decreased to 7.3 ,ug/g. The highest MMH levels
measured in brain tissue was 2.0,ug/g at 72 and 168
hr, and this caused about a 10% reduction in AChE
levels (Fig. 3). The lack of AChE depression prior
to 72 hr demonstrates the lag period described by
Clarkson (8). This experiment was somewhat
different from the carbaryl-MMH LD5o experi-
ment (1), which consisted oftwo 10 mg/kg doses of
MMH prior to dosing with carbaryl. However, the
reduction in AChE and ButChE levels for our
time-course studies are compatible withthe toxicity
associated with the LD5o experiments. The single
SC dose and limited number ofanimals used in this
study limit quantitative (p value) interpretation
but suggest an inverse relationship between MMH
levels and enzyme activity.
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FIGURE 3. Time-course experiment showing the effect of a
single SC dose of methylmercury hydroxide (MMH) (10
mg/kg) on the level of brain acetylcholinesterase in female
rats. Differences between (o) control and ( * ) treated
animals occurred at 2 (p=0.5), 72 (p=0.027) and 168 hr
(p=0.13); mercury levels (A), right margin. Eachp value is
based on three control and three treated animals.
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FIGURE 2. Time-course experiment showing the effect of a
single SC dose of methylmercury hydroxide (MMH) (10
mg/kg) on the plasma cholinesterase of female rats.
Differences between (o) control and (*) treated animals oc-
curred at 24 (p=0.15), 72 (p0.31), 168 (p=-0.08) and 336 hr
(p=0.13; mercury levels (A), right margin. Eachp value is
based on three control and three treated animals.
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To ascertain whether the reduction in ButChE
by MMH was the result ofdirect inhibition or some
other factor, the Michaelis constant Km and max-
imum velocity value Vmax for the substrate,
butyrylcholine, were determined for control and
FIGURE 4. Lineweaver-Burk plots for butyrylcholine and
plasma cholinesterase from pooled plasma of ( * ) control
and (o) methylmercury hydroxide-treated females (1 mg/kg/2
days sc). Each point represents two determinations on separ-
ate pH stats. For treated animals Km was 9.35 x 10-5M and
Vmax was 0.386 ,umole/min-ml; control animals had a Km of
8.53 x 10-5M while Vmax was 0.533 ,umole/min-ml.
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129MMH-treated (1.0 mg/kg for 2 days) females.
Figure 4 indicates that MMH effectively reduced
Vmax (control, 0.533; treated, 0.386 ,umole/min-ml)
while not affecting Km (control, 853 x 10-5M; treat-
ed, 9.35 x 10-5 M). Finally, an in vitro experiment
was conducted by incubating 4.3 x 10-4M MMH
with control ButChE for 0, 3, 20, and 120 min at
25°C and pH 7.0. No loss in ability to hydrolyze
butyrylcholine was observed. Obviously, the effect
of MMH is not direct inhibition.
It was recently shown that ButChE is composed
offour nonactive subunits or monomers (molecular
weight MW 77,300), two active subunits or dimers
(MW 143,000), and one active tetrameric form
(MW 315,000) (11). Sodium dodecyl sulfate (SDS)
(which breaks noncovalent bonds) converts the
tetramer to the dimer, but SDS and 2-mercap-
toethanol (which break disulfide bonds) are re-
quired to convert the dimer to the monomer. Thus,
it seems evident that the inactive monomeric form
of ButChE has a free sulfhydryl which would be
susceptible to covalent bonding by MMH. On
assuming the formation of the active enzyme de-
pends upon agglomeration of the nonactive
monomers, our data suggest MMH prevents forma-
tion ofactive enzyme. Clearlythein vitro studysup-
ports this contention since the active enzyme does
not contain free sulfhydryl groups and would not
be affected by MMH. The structural similarity of
AChE (12,13) and ButChE suggests a similar
mechanism of reaction for MMH and the
monomeric form of AChE; however, the slow rate
of MMH accumulation in the brain does afford
some protection.
The combination of reducing the formation of
ButChE and AChE and increasing the degradation
of hepatic cytochrome P-450 (2) would explain the
lower LD50 value of carbaryl to rats pretreated
with MMH. This should be true for MMH and any
cholinesterase-inhibiting pesticide which is pri-
marily detoxified by the mixed function oxidase
system.
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